| USGOV-DEPARTMENT-OF-DEFENSE |
USGOV-DEPARTMENT-OF-DEFENSE |
95%
|
USAspending awards from Department of Defense: $5,144,975 across 3 awards. W91YTZ21C0003 INFECTIOUS DISEASE REAGENTS CT/GT- NAAT; W81K0022P0084 DIMENSIONS 3D 900; W81K0022P0120 MAMMOGRAPY UNITS FULL … |
| USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES |
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES |
95%
|
USAspending awards from Department of Health and Human Services: $22,300,000 across 1 awards. 75A50122C00074 THE PURPOSE IS TO ENSURE TEST AVAILABILITY FOR SARS-COV-2 AFTER THE EMERGENCY AUTHORIZATIO… |
| USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS |
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS |
95%
|
USAspending awards from Department of Veterans Affairs: $6,908,057 across 6 awards. 36C24826N0327 EQUIPMENT MAINTENANCE; 36C24825N0365 EQUIPMENT MAINTENANCE; 36C25821C0004 HOLOGIC EQUIPMENT PREVENTAT… |
| DIAGNOSTICS-SEGMENT-CUSTOMERS |
DIAGNOSTICS-SEGMENT-CUSTOMERS |
90%
|
a material portion of product sales in our Diagnostics segment comes from (and we anticipate will continue to come from) a limited number of customers, two of which accounted for 12.8% and 10.1% of o… |
| JNJ |
Johnson & Johnson |
72%
|
Reciprocal relationship from JNJ graph: Reciprocal relationship from HOLX graph: competitors are large imaging companies such as Siemens Healthineers and GE Healthcare, as well as a wide range of med… |
| JNJ |
Johnson & Johnson |
72%
|
competitors are large imaging companies such as Siemens Healthineers and GE Healthcare, as well as a wide range of medical technology companies that sell a subset of technology solutions into a speci… |
| JPM-PD |
JPMorgan Chase & Co. |
72%
|
other non-cash taxes ( 72.1 ) ( 109.1 ) ( 166.2 ) Intangible assets and equipment impairment charges 44.8 223.8 45.1 Loss on assets held-for-sale — 51.7 — Contingent consideration fair value adjustme… |
| JPM-PD |
JPMorgan Chase & Co. |
72%
|
Reciprocal relationship from JPM-PD graph: Reciprocal relationship from HOLX graph: Reciprocal relationship from JPM-PD graph: Reciprocal relationship from HOLX graph: Reciprocal relationship from JP… |
| ACESSA-HEALTH-INC |
ACESSA-HEALTH-INC |
62%
|
names. During the third quarter of fiscal 2024, as discussed above, we recorded an additional impairment charge related to our BioZorb product line of $13.7 million of which $0.4 million was allocate… |
| BOLDER-SURGICAL-HOLDINGS-INC |
BOLDER-SURGICAL-HOLDINGS-INC |
62%
|
ics region of Europe. The Company allocated $ 3.0 million of the purchase price to a customer relationship intangible asset with a useful life of 5 years, and the excess of the purchase price over th… |
| DELAWARE-GENERAL-CORPORATION |
DELAWARE-GENERAL-CORPORATION |
62%
|
lating to current products will expire in the U.S. and abroad thus allowing third parties to utilize certain of our technologies. Our business could be harmed if we infringe upon the intellectual pro… |
| FAXITRON-BIOPTICS-LLC |
FAXITRON-BIOPTICS-LLC |
62%
|
its Mobidiag IPR&D intangible asset. The Company determined the fair value of the asset utilizing a DCF model and recorded a $ 27.7 million impairment charge. The reduction in fair value was due to a… |
| F-HOFFMANN-LAROCHE-LTD |
F-HOFFMANN-LAROCHE-LTD |
62%
|
pliers are competitors. For example, F. Hoffmann-LaRoche Ltd, a direct competitor of our Diagnostics business, is the parent company of Roche, our current supplier of certain key raw materials for ce… |
| FOCAL-THERAPEUTICS-INC |
FOCAL-THERAPEUTICS-INC |
62%
|
its Mobidiag IPR&D intangible asset. The Company determined the fair value of the asset utilizing a DCF model and recorded a $ 27.7 million impairment charge. The reduction in fair value was due to a… |
| GE-HEALTHCARE-BIO-SCIENCES-CORP |
GE-HEALTHCARE-BIO-SCIENCES-CORP |
62%
|
he, our current supplier of certain key raw materials for certain of our amplified NAT diagnostic assays. GE Healthcare Bio-Sciences Corp., an affiliate of GE, supplies us with the membranes used in … |
| JW-MEDICAL-CORPORATION |
JW-MEDICAL-CORPORATION |
62%
|
synergistic benefits that are expected to be realized from the Endomag acquisition. These benefits include expanding the Company’s breast care portfolio and utilizing Breast Health’s sales and regula… |
| OPERATIONS-HOLOGIC-INC |
OPERATIONS-HOLOGIC-INC |
62%
|
other non-cash taxes ( 72.1 ) ( 109.1 ) ( 166.2 ) Intangible assets and equipment impairment charges 44.8 223.8 45.1 Loss on assets held-for-sale — 51.7 — Contingent consideration fair value adjustme… |
| SSH-HOLDINGS-LIMITED |
SSH-HOLDINGS-LIMITED |
62%
|
scount rate driven by market rates. The Company paid $ 12.2 million for the first earnout period. 6. Strategic Investments Maverix Medical On November 13, 2023, the Company entered into an agreement … |
